aap Implantate AG (AAQ1.DE)
Company Info
ISIN | DE000A3H2101 |
---|---|
Sector | Healthcare |
Industry | Medical Devices |
Highlights
Market Cap | €9.07M |
---|---|
EPS | -€0.27 |
Revenue (TTM) | €11.96M |
Gross Profit (TTM) | €10.55M |
EBITDA (TTM) | -€3.05M |
Year Range | €0.70 - €1.46 |
Target Price | €0.80 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of €10,000 in aap Implantate AG, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
aap Implantate AG had a return of 39.76% year-to-date (YTD) and -17.14% in the last 12 months. Over the past 10 years, aap Implantate AG had an annualized return of -28.13%, while the S&P 500 had an annualized return of 10.37%, indicating that aap Implantate AG did not perform as well as the benchmark.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | 39.76% | 5.57% |
1 month | 51.63% | -4.16% |
6 months | 38.92% | 20.07% |
1 year | -17.14% | 20.82% |
5 years (annualized) | -36.76% | 11.56% |
10 years (annualized) | -28.13% | 10.37% |
Monthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | -3.61% | -8.13% | 4.08% | |||||||||
2023 | -0.60% | -1.20% | 0.61% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of AAQ1.DE is 33, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
aap Implantate AG(AAQ1.DE)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for aap Implantate AG (AAQ1.DE) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the aap Implantate AG. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the aap Implantate AG was 99.58%, occurring on Feb 9, 2024. The portfolio has not yet recovered.
The current aap Implantate AG drawdown is 99.33%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-99.58% | Mar 2, 2000 | 5942 | Feb 9, 2024 | — | — | — |
-35.32% | Nov 9, 1999 | 14 | Nov 29, 1999 | 60 | Feb 23, 2000 | 74 |
-15.12% | Jun 1, 1999 | 9 | Jun 17, 1999 | 11 | Jul 5, 1999 | 20 |
-14.78% | Jul 20, 1999 | 11 | Aug 5, 1999 | 14 | Aug 25, 1999 | 25 |
-12.14% | Sep 21, 1999 | 4 | Sep 24, 1999 | 8 | Oct 11, 1999 | 12 |
Volatility
Volatility Chart
The current aap Implantate AG volatility is 24.29%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
TTM | |
---|---|
Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |